Apyx Medical Corporation

NASDAQ: APYX · Real-Time Price · USD
2.17
0.05 (2.36%)
At close: Aug 15, 2025, 11:56 AM

Apyx Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-23.56M -18.85M -23.28M -15.2M
Depreciation & Amortization
599K 692K 890K 903K
Stock-Based Compensation
4.01M 5.11M 6.7M 5.09M
Other Working Capital
-1.41M 88K -1.63M 4.76M
Other Non-Cash Items
2.15M 2.25M 628K 603K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.25M 5.54M -5.22M -1.84M
Operating Cash Flow
-18.05M -5.25M -20.28M -10.45M
Capital Expenditures
-722K -533K -1.01M -723K
Cash Acquisitions
n/a 7.41M n/a 195K
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -147K n/a -195K
Investing Cash Flow
-722K 6.73M -1.01M -723K
Debt Repayment
-20K 35.04M -148K -238K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-235K -5.59M n/a 195K
Financial Cash Flow
6.75M 32.17M 217K 24K
Net Cash Flow
-11.91M 33.46M -20.68M -11.04M
Free Cash Flow
-18.77M -5.78M -21.29M -11.17M